Ouro Fino Saúde Animal Participações Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Ouro Fino Saúde Animal Participações.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth	19.5%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

Recent updates

We Think Ouro Fino Saúde Animal Participações' (BVMF:OFSA3) Healthy Earnings Might Be Conservative

Aug 15

One Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3) Analyst Just Cut Their EPS Forecasts

May 19

Is Ouro Fino Saúde Animal Participações (BVMF:OFSA3) A Risky Investment?

Dec 20

These 4 Measures Indicate That Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Using Debt Reasonably Well

Jul 28

We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Can Stay On Top Of Its Debt

Feb 01

Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Has A Pretty Healthy Balance Sheet

May 27

Is Now The Time To Put Ouro Fino Saúde Animal Participações (BVMF:OFSA3) On Your Watchlist?

Mar 01

Does Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Have A Healthy Balance Sheet?

Feb 08

Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Jan 21

Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Growing Earnings But Are They A Good Guide?

Jan 03

Introducing Ouro Fino Saúde Animal Participações (BVMF:OFSA3), A Stock That Climbed 42% In The Last Three Years

Dec 15

Should You Be Adding Ouro Fino Saúde Animal Participações (BVMF:OFSA3) To Your Watchlist Today?

Nov 27

What You Can Learn From Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) P/E

Aug 09

We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Taking Some Risk With Its Debt

Jul 13

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ouro Fino Saúde Animal Participações has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

BOVESPA:OFSA3 - Analysts future estimates and past financials data (BRL Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2024	959	91	19	65	N/A
6/30/2024	940	54	105	153	N/A
3/31/2024	954	-34	127	176	N/A
12/31/2023	943	-50	143	190	N/A
9/30/2023	985	-23	187	236	N/A
6/30/2023	1,002	17	123	181	N/A
3/31/2023	1,006	111	106	166	N/A
12/31/2022	1,041	131	20	90	N/A
9/30/2022	989	122	-39	32	N/A
6/30/2022	943	112	-1	65	N/A
3/31/2022	939	120	-33	34	N/A
12/31/2021	905	114	-20	47	N/A
9/30/2021	855	108	20	68	N/A
6/30/2021	845	119	32	69	N/A
3/31/2021	787	101	61	92	N/A
12/31/2020	730	90	87	112	N/A
9/30/2020	706	83	76	112	N/A
6/30/2020	635	50	33	77	N/A
3/31/2020	640	50	12	60	N/A
12/31/2019	620	46	4	56	N/A
9/30/2019	598	40	28	75	N/A
6/30/2019	604	50	29	80	N/A
3/31/2019	588	60	3	58	N/A
12/31/2018	589	69	-5	43	N/A
9/30/2018	576	72	-3	43	N/A
6/30/2018	546	60	N/A	46	N/A
3/31/2018	522	49	N/A	79	N/A
12/31/2017	505	38	N/A	100	N/A
9/30/2017	442	3	N/A	91	N/A
6/30/2017	437	0	N/A	82	N/A
3/31/2017	434	-9	N/A	61	N/A
12/31/2016	457	-5	N/A	42	N/A
9/30/2016	523	31	N/A	27	N/A
6/30/2016	547	44	N/A	34	N/A
3/31/2016	545	58	N/A	17	N/A
12/31/2015	534	69	N/A	16	N/A
9/30/2015	580	61	N/A	17	N/A
6/30/2015	459	50	N/A	13	N/A
3/31/2015	414	46	N/A	20	N/A
12/31/2014	402	43	N/A	5	N/A
12/31/2013	384	54	N/A	33	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if OFSA3's forecast earnings growth is above the savings rate (10.4%).

Earnings vs Market: Insufficient data to determine if OFSA3's earnings are forecast to grow faster than the BR market

High Growth Earnings: Insufficient data to determine if OFSA3's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if OFSA3's revenue is forecast to grow faster than the BR market.

High Growth Revenue: Insufficient data to determine if OFSA3's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if OFSA3's Return on Equity is forecast to be high in 3 years time

Ouro Fino Saúde Animal Participações Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Consensus EPS estimates fall from profit to R$0.25 loss

Price target decreased by 7.4% to R$25.00

Consensus EPS estimates fall by 23%

Price target increased to R$38.00

Analysts increase EPS estimates to R$1.23

Analysts lower EPS estimates to R$1.01

Recent updates

New major risk - Revenue and earnings growth

Third quarter 2024 earnings released: EPS: R$0.77 (vs R$0.077 in 3Q 2023)

Now 24% overvalued after recent price rise

We Think Ouro Fino Saúde Animal Participações' (BVMF:OFSA3) Healthy Earnings Might Be Conservative

Second quarter 2024 earnings released: EPS: R$0.31 (vs R$1.31 loss in 2Q 2023)

New major risk - Revenue and earnings growth

Ouro Fino Saúde Animal Participações S.A. to Report Q3, 2024 Results on Nov 07, 2024

Ouro Fino Saúde Animal Participações S.A. to Report Q2, 2024 Results on Aug 08, 2024

First quarter 2024 earnings released: EPS: R$0.24 (vs R$0.063 loss in 1Q 2023)

Upcoming dividend of R$0.34 per share

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Ouro Fino Saúde Animal Participações S.A., Annual General Meeting, Apr 19, 2024

Ouro Fino Saúde Animal Participações S.A. to Report Q4, 2023 Results on Mar 07, 2024

Third quarter 2023 earnings released: EPS: R$0.077 (vs R$0.83 in 3Q 2022)

Ouro Fino Saúde Animal Participações S.A. to Report Q3, 2023 Results on Nov 09, 2023

Consensus EPS estimates fall from profit to R$0.25 loss

Price target decreased by 7.4% to R$25.00

New minor risk - Profit margin trend

Second quarter 2023 earnings released

Ouro Fino Saúde Animal Participações S.A. to Report Q2, 2023 Results on Aug 10, 2023

One Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3) Analyst Just Cut Their EPS Forecasts

Consensus EPS estimates fall by 23%

First quarter 2023 earnings released

Upcoming dividend of R$0.20 per share at 0.8% yield

Full year 2022 earnings released

Ouro Fino Saúde Animal Participações S.A., Annual General Meeting, Apr 14, 2023

Investor sentiment improved over the past week

Is Ouro Fino Saúde Animal Participações (BVMF:OFSA3) A Risky Investment?

Ouro Fino Saúde Animal Participações S.A. to Report Q4, 2022 Results on Mar 02, 2023

Third quarter 2022 earnings released: EPS: R$0.83 (vs R$0.65 in 3Q 2021)

Third quarter 2022 earnings released

Second quarter 2022 earnings released

These 4 Measures Indicate That Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Using Debt Reasonably Well

Ouro Fino Saúde Animal Participações S.A. to Report Q2, 2022 Results on Aug 04, 2022

Ouro Fino Saúde Animal Participações S.A. to Report Q3, 2022 Results on Nov 10, 2022

First quarter 2022 earnings: Revenues in line with analyst expectations

Ouro Fino Saúde Animal Participações S.A. to Report Q1, 2022 Results on May 12, 2022

Upcoming dividend of R$0.24 per share

Full year 2021 earnings: EPS exceeds analyst expectations

Ouro Fino Saúde Animal Participações S.A. to Report Q4, 2021 Results on Feb 24, 2022

Investor sentiment improved over the past week

We Think Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Can Stay On Top Of Its Debt

Price target increased to R$38.00

Third quarter 2021 earnings released: EPS R$0.65 (vs R$0.84 in 3Q 2020)

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Second quarter 2021 earnings released: EPS R$0.59 (vs R$0.27 in 2Q 2020)

Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Has A Pretty Healthy Balance Sheet

First quarter 2021 earnings released

Inaugural dividend of R$0.17 per share

Revenue beats expectations

Full year 2020 earnings released: EPS R$1.66 (vs R$0.86 in FY 2019)

Is Now The Time To Put Ouro Fino Saúde Animal Participações (BVMF:OFSA3) On Your Watchlist?

New 90-day low: R$32.40

Does Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Have A Healthy Balance Sheet?

Ouro Fino Saúde Animal Participações S.A. to Report Q4, 2020 Results on Mar 04, 2021

Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Ouro Fino Saúde Animal Participações (BVMF:OFSA3) Is Growing Earnings But Are They A Good Guide?

New 90-day high: R$36.50

Introducing Ouro Fino Saúde Animal Participações (BVMF:OFSA3), A Stock That Climbed 42% In The Last Three Years

New 90-day high: R$36.15

Analysts increase EPS estimates to R$1.23

Should You Be Adding Ouro Fino Saúde Animal Participações (BVMF:OFSA3) To Your Watchlist Today?

New 90-day high: R$31.00

Ouro Fino Saúde Animal Participações S.A. to Report Q3, 2020 Results on Nov 09, 2020

Analysts lower EPS estimates to R$1.01

Price target lowered to R$33.25